Profile cover photo
Profile photo
PBIRX
3 followers
3 followers
About
Posts

Post has attachment
#ThoughtThursday I wish I could get rid of this nagging arthritis pain!

Your solution could be out there on the market 👇
Add a comment...

Post has attachment
New Cancer Drug Approved

The FDA has just approved the Novartis drug Kymriah, a groundbreaking treatment intended to cure a patient’s cancer. The AWP cost is an estimated $570,000 and the WAC is $475,000. This is the first gene therapy approved by the FDA; a one-time treatment using the patient’s own T cells to fight cancer.

Learn More» http://bit.ly/2j3wlbV
Photo
Add a comment...

Post has attachment
Is the PPACA Annual Tax on Branded Drugs Contributing to Higher Drug Costs?

Hidden in the many pages of the original 2010 Patient Protection and Affordable Care Act (ACA), is Section 9008 from the Internal Revenue Service, which requires an annual fee on each covered entity engaged in the business of manufacturing or importing branded prescription drugs to “specific government programs”, to be paid not later than September 30th of each year. “Specific government programs” refers to Medicare Parts B and D, Medicaid, Department of Veterans Affairs, Department of Defense and the Tricare retail pharmacy program.

Learn More» http://bit.ly/2tjLBl0
Photo
Add a comment...

Post has attachment
Voluntary Drug Recall

Lupin Pharmaceuticals, Inc. has announced that they voluntarily recalled Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1mg/0.02 mg chewable and ferrous furnarate 75mg) Tabelts -- Lot L600518 with an expiration date of 5/18.

Learn More» http://bit.ly/2rOkXQA
Photo
Add a comment...

Post has attachment
Auditing PBM Agreements Can Save Money

Pharmacy Benefit Managers love when their clients do NOT audit their pharmacy benefit agreement! This way the creative language in their contracts is not revealed and you pay more and more each month and each year.

Learn More» http://bit.ly/2s8E7VJ
Photo
Add a comment...

Post has attachment
Glucose Meters and Test Strip Tips for Diabetes Patients

Glucose meters and test strips are sold with instructions for use. You can call the manufacturer of your device or your health care provider if you have questions.

Learn More» http://bit.ly/2rBqsoJ
Photo
Add a comment...

Post has attachment
New Rheumatoid Arthritis Drug

On May 22, 2017, the FDA approved a new drug, Kevzara (sarilumab), manufactured by Sanofi/Regeneron Pharmaceuticals, indicated to treat adults with moderate-to-severe rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs. The patient receives one injection every two weeks at a cost of approximately $39,000 per year.

Learn More» http://bit.ly/2rVqq9p
Photo
Add a comment...

Post has attachment
Diabetes Drug Safety Communication

PBIRx has been informed by the FDA Safety Information and Adverse Event Reporting of increased risk of leg and foot amputations with the use of canagliflozin brands (Invokana, Invokamet, Invokamet XR). The FDA will be requiring new warnings including Boxed Warning to be added to the canagliflozin drug labels to describe the risk.

Learn More» http://bit.ly/2q42zlG
Photo
Add a comment...

Post has attachment
FDA Approves ALS Drug

On Friday, May 5th, for the first time in 22 years, the FDA approved Radicava (edaravone) to treat patients with ALS, also known as Lou Gehrig’s disease. The Centers for Disease Control and Prevention estimates that there are approximately 12,000 to 15,000 Americans who have this disease, which attacks and kills nerve cells that control voluntary muscles. A year’s course of the medicine will cost about $145,000 before discounts.

Learn More» http://bit.ly/2pvXN13
Photo
Add a comment...

Post has attachment
EpiPen Voluntary Recall

On Friday, March 31, the FDA alerted consumers to the voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr Auto-Injector products that are used for emergency treatment of severe allergic reactions. The recalled products were distributed from December 2015 through July 2016. These devices may contain a defective part that could result in its failure to activate. This recall impacts the 0.3mg and 0.15mg strengths.

Learn More» http://bit.ly/2nZ0n1c
Photo
Add a comment...
Wait while more posts are being loaded